73 results on '"TURA, SANTE"'
Search Results
2. Unraveling the mechanisms behind iron overload and ineffective hematopoiesis in myelodysplastic syndromes
3. Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders–A consensus project of the Italian Society of Hematology
4. Brentuximab Vedotin in CD30-Positive Lymphomas: A SIE, SIES, and GITMO Position Paper
5. Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation Guidelines for the Management of Indolent, Nonfollicular B-Cell Lymphoma (Marginal Zone, Lymphoplasmacytic, and Small Lymphocytic Lymphoma)
6. Appropriate use of bendamustine in first-line therapy of chronic lymphocytic leukemia. Recommendations from SIE, SIES, GITMO Group
7. Identifying and addressing unmet clinical needs in Ph-neg classical myeloproliferative neoplasms: A consensus-based SIE, SIES, GITMO position paper
8. SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia
9. Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma
10. Immune therapy of chronic myelogenous leukemia
11. Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells
12. Acute graft-versus-host disease and steroid treatment impair CD11c + and CD123 + dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation
13. Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation
14. A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoid leukemias
15. Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6
16. Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study: Presented in part at the 43rd Annual Meeting of The American Society of Hematology, Orlando, FL, December 11, 2001.
17. Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study
18. A randomized study of interferon-α versus interferon-α and low-dose arabinosyl cytosine in chronic myeloid leukemia
19. Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma
20. Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state
21. Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic responders
22. Interleukin-11 induces Th2 polarization of human CD4+ T cells
23. Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma
24. Rapid Induction of CD40 on a Subset of Granulocyte Colony-Stimulating Factor–Mobilized CD34+ Blood Cells Identifies Myeloid Committed Progenitors and Permits Selection of Nonimmunogenic CD40− Progenitor Cells
25. Treatment and Clinical Management of Primary Mediastinal Large B-Cell Lymphoma With Sclerosis: MACOP-B Regimen and Mediastinal Radiotherapy Monitored by 67Gallium Scan in 50 Patients
26. An Evidence-Based Analysis of the Effect of Busulfan, Hydroxyurea, Interferon, and Allogeneic Bone Marrow Transplantation in Treating the Chronic Phase of Chronic Myeloid Leukemia: Developed for the American Society of Hematology: Presented in part at the Education Session of the American Society of Hematology, December 5, 1998, Miami Beach, FL.
27. Elderly Aggressive-Histology Non-Hodgkin's Lymphoma: First-Line VNCOP-B Regimen Experience on 350 Patients
28. Negative selection of autologous peripheral blood stem cells
29. Use of Lenalidomide in DEL(5q) MDS. a National AIFA (Agenzia Italiana del Farmaco) Registry Study
30. Deferasirox Chelation Therapy in Transfusion Dependent MDS Patients. Final Report From the Gimema MDS0306 Prospective Trial
31. Quality of Life in Elderly Patients with Essential Thrombocythemia.
32. Superiority of Double over Single Autologous Stem-Cell Transplantation for Newly Diagnosed Multiple Myeloma and Prognostic Impact of Complete Response: Final Analysis of “Bologna 96” Study.
33. Gene Expression Analysis of Peripheral T-Cell Lymphoma Not Otherwise Specified Reveals the Existance of Two Subgroups Related to Different Cellular Counterparts and Recurrent PDGFRA Deregulation.
34. Superiority of First-Line Thalidomide-Dexamethasone over Vincristine-Doxorubicin-Dexamethasone in Preparation for Autologous Stem Cell Transplantation for Multiple Myeloma.
35. Superiority of Double over Single Autologous Stem Cell Transplantation as First-Line Therapy for Multiple Myeloma.
36. Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy
37. 6The role of haematopoietic stem cell-supported myeloablative therapy for the management of multiple myeloma
38. Prognostic significance of lymphography in stage III s Hodgkin's disease (HD)
39. Hodgkin's disease (HD): A historical perspective
40. t(8;14)(q11;q32) in acute lymphoid leukemia: Description of two cases
41. Cytogenetic and molecular studies in patients with chronic myeloid leukemia and variant Philadelphia translocations
42. Chromosome studies in patients with acute nonlymphocytic or acute lymphocytic leukemia submitted to bone marrow transplantation—Results of a European cooperative study
43. Cytogenetic analyses in 89 patients with secondary hematologic disorders—Results of a cooperative study
44. Chromosome studies in patients with Philadelphia chromosome-positive chronic myeloid leukemia submitted to bone marrow transplantation—Results of a European cooperative study
45. Chromosome 12 rearrangement with breakage at the p11 level in hematologic disorders: Report of four cases
46. 21q− in primary thrombocythemia
47. Acute nonlymphocytic leukemias and dysmyelopoietic syndromes in patients treated for Hodgkin's lymphoma
48. GM-CSF incubation prior to treatment with cytarabine or doxorubicin enhances drug activity against AML cells in vitro: A model for leukemia chemotherapy
49. Cell flux studies during chemotherapy with multiple doses of arabinosyl cytosine in chronic myeloid leukemia
50. Low dose arabinosyl cytosine for treatment of myelodysplastic syndromes and subacute myeloid leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.